About Author : Anusha


Anusha

As a voracious reader and thinker, employing words has always been my preferred method of narration. Anusha’s conviction that a drop of ink possesses the ability to influence even the most stubborn minds has been strengthened by completing a Master’s degree in English Literature and then eventually working as a full-time writer.



Contribution by: Anusha

EA to launch three games based on Marvel, debuting first with Iron Man

California-based video games company, Electronic Arts Inc. is reportedly planning to develop three action-adventure video games centered around the Marvel universe. One of the video games centered around Iron Man would include an original narrative ...


Read More >>
Bob Evans recalls 7,500 pounds of Italian pork sausage amid complaints

Bob Evans Farms Foods, a subsidiary of Bob Evans Restaurants, a renowned American restaurant chain recently took a decision of recalling nearly 7,500 pounds of Italian pork sausage that were manufactured on 8th September 2022, amid rising consumer co...


Read More >>
Indegene acquires U.S.-based healthcare marketing agency Cult Health

Bengaluru-based Indegene Inc. a company that provides R&D and management services for pharmaceutical corporations has reportedly completed the acquisition of U.S.-based healthcare marketing agency CultHealth. Although the financial parameters of...


Read More >>
Apple Music brings spatial audio to certain Mercedes Benz models

German luxury and commercial vehicles conglomerate, Mercedes Benz AG has recently announced that it would integrate Apple Musics spatial audio offering into select car models of the company. After launching the spatial audio system with Dolby Atmos ...


Read More >>
SEBI greenlights Kaynes Technology’s attempt to raise funds through IPO

As per recent citations, Mysore-based Kaynes Technology Inc. has received a go from SEBI to raise funds by the way of an Initial Public Offering (IPO). The Draft Red Herring Prospectus (DRHP) cites that the IPO includes a fresh issue of equity share...


Read More >>
Tilt announces partnership with MSD for immunotherapy clinical trials

Tilt Biotherapeutics Ltd. has recently announced a partnership deal with MSD (trade name of Merck & Co.), wherein the two pharmaceutical giants would focus on combining their resources toward evaluating a new clinical trial on TILT-123. For thos...


Read More >>